Selvaraj Brinda, Kocaman Seda, Trifas Maria, Serpersu Engin H, Cuneo Matthew J
Neutron Sciences Directorate, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.
The Department of Biochemistry and Cellular and Molecular Biology, The University of Tennessee, 1311 Cumberland Ave, Knoxville, Tennessee 37916, United States.
ACS Catal. 2020 Mar 20;10(6):3548-3555. doi: 10.1021/acscatal.9b05201. Epub 2020 Feb 18.
Nucleotidyl transfer is an archetypal enzyme reaction central to DNA replication and repair. Here we describe a variation of the nucleotidylation reaction termed "catch and release" that is used by an antibiotic modifying enzyme. The aminoglycoside nucleotidyl transferase 4' (ANT4') inactivates antibiotics such as kanamycin and neomycin through nucleotidylation within an active site that shares significant structural, and inferred underlying catalytic similarity, with human DNA polymerase beta. Here we follow the entire nucleotidyl transfer reaction coordinate of ANT4' covalently inactivating neomycin using X-ray crystallography. These studies show that although the underlying reaction mechanism is conserved with polymerases, a short 2.35 A hydrogen bond is initially formed to facilitate tight binding of the aminoglycoside substrate and is subsequently disrupted by the assembly of the catalytically active ternary complex. This enables the release of products post catalysis due to a lower free energy of the product state compared to the starting substrate complex. We propose that this "catch and release" mechanism of antibiotic turnover observed in ANT4' is a variation of nucleotidyl transfer that has been adapted for the inactivation of antibiotics.
核苷酸转移是一种在DNA复制和修复中至关重要的典型酶促反应。在此,我们描述了一种被抗生素修饰酶所采用的名为“捕获与释放”的核苷酸化反应变体。氨基糖苷类核苷酸转移酶4'(ANT4')通过在一个与人类DNA聚合酶β具有显著结构以及推测的潜在催化相似性的活性位点内进行核苷酸化,使卡那霉素和新霉素等抗生素失活。在此,我们利用X射线晶体学追踪ANT4'共价使新霉素失活的整个核苷酸转移反应过程。这些研究表明,尽管其潜在反应机制与聚合酶是保守的,但最初会形成一个短的2.35埃氢键以促进氨基糖苷类底物的紧密结合,随后该氢键会被催化活性三元复合物的组装所破坏。这使得催化后产物能够释放,因为与起始底物复合物相比,产物状态的自由能更低。我们提出,在ANT4'中观察到的这种抗生素周转的“捕获与释放”机制是一种已适应于使抗生素失活的核苷酸转移变体。